Multiple Carboxylase Deficiency
What is Multiple Carboxylase Deficiency?
Multiple carboxylase deficiency is a rare genetic disorder that affects how your body uses biotin, also known as vitamin B7. When this condition occurs, your body cannot properly activate several important enzymes called carboxylases. These enzymes help break down proteins, fats, and carbohydrates for energy.
There are two main types of this condition. Holocarboxylase synthetase deficiency usually appears in infancy. Biotinidase deficiency often shows up in the first few months of life. Both types prevent your body from recycling and using biotin effectively.
Without enough working carboxylase enzymes, harmful acids build up in your blood and tissues. This can affect your brain, skin, immune system, and overall development. Early detection and treatment are critical for preventing serious complications and supporting normal growth.
Symptoms
- Skin rashes, especially around the eyes, nose, and mouth
- Hair loss or thinning hair
- Seizures or unusual movements
- Weak muscle tone or floppy limbs
- Difficulty feeding or poor appetite
- Vomiting or nausea
- Breathing problems or rapid breathing
- Developmental delays or regression
- Hearing loss or vision problems
- Lethargy or decreased alertness
Symptoms can range from mild to severe depending on the type and how early treatment begins. Some infants may appear healthy at birth but develop symptoms within weeks or months. Without treatment, symptoms typically worsen over time.
Concerned about Multiple Carboxylase Deficiency? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Multiple carboxylase deficiency is caused by genetic mutations passed down from parents. It follows an autosomal recessive pattern, meaning a child must inherit one faulty gene from each parent to develop the condition. Parents who carry one copy of the gene usually show no symptoms themselves.
The two types result from mutations in different genes. Holocarboxylase synthetase deficiency comes from mutations in the HLCS gene. Biotinidase deficiency results from mutations in the BTD gene. These genetic changes prevent enzymes from working properly, leading to biotin deficiency even when dietary biotin intake is normal. Risk factors include having parents who are carriers or having a family history of the condition.
How it's diagnosed
Diagnosis typically begins with newborn screening programs in many states. These screenings can detect biotinidase deficiency in the first days of life. If screening suggests a problem, doctors order specialized tests to confirm the diagnosis and determine the specific type.
Blood and urine tests can reveal elevated organic acids that indicate carboxylase enzyme problems. Genetic testing identifies the specific mutations causing the condition. Enzyme activity tests measure how well biotinidase or holocarboxylase synthetase is working. Talk to your doctor about specialized testing if you suspect this condition. While basic biotin levels can be checked, diagnosing multiple carboxylase deficiency requires specific enzyme and genetic tests.
Treatment options
- High-dose biotin supplementation, usually 5 to 20 milligrams daily for life
- Regular monitoring of biotin levels and enzyme function
- Dietary adjustments to avoid raw egg whites, which block biotin absorption
- Management of acute symptoms during metabolic crises
- Physical therapy for developmental delays
- Hearing and vision assessments and support
- Genetic counseling for families
- Emergency protocols during illness or stress
Most people with this condition respond very well to biotin therapy when started early. Treatment is lifelong and must be continued even when symptoms improve. Regular follow-up with a metabolic specialist helps ensure proper management and prevents complications.
Frequently asked questions
Multiple carboxylase deficiency is a rare inherited disorder that affects how your body uses biotin, or vitamin B7. The condition prevents several important enzymes from working properly, leading to a buildup of harmful acids. Early treatment with biotin supplements can prevent serious complications and support normal development.
This condition is very rare, affecting roughly 1 in 60,000 to 1 in 140,000 newborns worldwide. Biotinidase deficiency is the more common of the two types. Many states include screening for biotinidase deficiency in their newborn screening programs, which helps identify affected babies early.
There is no cure for this genetic condition, but it can be managed very effectively with lifelong biotin supplementation. When treatment starts early, most children develop normally and live healthy lives. The key is consistent daily biotin intake and regular medical monitoring to prevent complications.
Without treatment, this condition can cause seizures, developmental delays, hearing loss, vision problems, and immune system weakness. Severe cases may lead to coma or life-threatening metabolic crises. However, early detection through newborn screening and prompt biotin treatment can prevent most of these serious outcomes.
Diagnosis often starts with newborn screening, which can detect biotinidase deficiency. Confirmatory tests include enzyme activity measurements, urine organic acid analysis, and genetic testing. These specialized tests identify which type of multiple carboxylase deficiency is present and guide treatment decisions.
People with multiple carboxylase deficiency should avoid raw egg whites, which contain a protein called avidin that blocks biotin absorption. Cooked eggs are safe because heat destroys avidin. Otherwise, a normal balanced diet is appropriate as long as biotin supplementation continues daily.
Yes, this condition is inherited in an autosomal recessive pattern. A child must receive one faulty gene from each parent to develop the disorder. Parents who carry one copy of the gene are typically healthy but have a 25 percent chance with each pregnancy of having an affected child.
Treatment typically requires 5 to 20 milligrams of biotin daily, which is much higher than normal dietary amounts. The exact dose depends on the type of deficiency and individual response to treatment. A metabolic specialist will determine the right dose and adjust it based on regular monitoring and symptom control.
Multiple carboxylase deficiency is a genetic condition present from birth, not something that develops later in life. However, some people with milder forms may not show symptoms until later in childhood or even adulthood if they were not screened as newborns. Once diagnosed, the same biotin treatment applies regardless of age at diagnosis.
If treatment begins early and is maintained consistently, most children develop normally and do not need special education services. Delays in diagnosis or treatment can lead to developmental challenges that may require support. Regular developmental assessments help identify any areas where a child might benefit from early intervention or therapy.